| A Phase 3 Study to Compare Biosimilar Denosumab With Prolia® (NCT05405725) | Enzene Biosciences Ltd. | 2022-07-04 |
| Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis (NCT05278338) | Shanghai JMT-Bio Inc. | 2022-04-21 |
| Anabolic Therapy in Postmenopausal Osteoporosis (NCT05010590) | Massachusetts General Hospital | 2022-03-24 |
| Pravastatin Reduces Acute Phase Response of Zoledronic Acid (NCT04719481) | Peking University Third Hospital | 2021-11-01 |
| Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid (NCT04719650) | Peking University Third Hospital | 2021-10-01 |
| Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis (NCT05087030) | Gedeon Richter Plc. | 2021-09-21 |
| Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults (NCT04940845) | Shanghai Hansoh Biomedical Co., Ltd | 2021-07-26 |
| Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk (NCT04431960) | University of Connecticut | 2021-07-20 |
| Compare the Agility Exercise and Resistance Exercise on Physical Function and Stability in Osteoporotic Women (NCT06457308) | Tainan Hospital, Ministry of Health and Welfare | 2021-07-14 |
| Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients (NCT05346419) | Hospital Regional 1o de Octubre | 2021-07-01 |
| A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis (NCT04934072) | Fresenius Kabi SwissBioSim GmbH | 2021-06-16 |
| Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment (NCT05347082) | Hospital Regional 1o de Octubre | 2021-04-29 |
| Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® . (NCT04591275) | Shanghai Biomabs Pharmaceutical Co., Ltd. | 2021-03-31 |
| Translation and Cross -Cultural Validation of ECOS-16 Questionnaire in Urdu Language (NCT04873960) | Riphah International University | 2021-03-15 |
| High Intensity Multi-Modal Exercise Training in Postmenopausal Women (NCT04653350) | Riphah International University | 2020-11-01 |
| How Vertebral Fractures Effect Balance In Postmenopausal Women (NCT06502301) | Istanbul University - Cerrahpasa | 2020-11-01 |
| Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults (NCT04747392) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2020-08-19 |
| Efficacy of Denosumab Treatment in Bisphosphonate Unresponsive Patients (NCT04702204) | Nigde Omer Halisdemir University | 2020-07-01 |
| Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation (NCT04338529) | 251 Hellenic Air Force & VA General Hospital | 2020-04-01 |
| Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri (NCT04169789) | Sahlgrenska University Hospital | 2019-12-04 |
| Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration (NCT04026256) | Massachusetts General Hospital | 2019-09-02 |
| Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis (NCT04064411) | Radius Health, Inc. | 2019-08-05 |
| Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteers (NCT03925051) | Shanghai Biomabs Pharmaceutical Co., Ltd. | 2019-07-01 |
| Quality of Life in Postmenopausal Women With Osteoporosis (NCT03970902) | University Ghent | 2019-07-01 |
| A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture (NCT05060406) | Luye Pharma Group Ltd. | 2019-06-30 |
| Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD) (NCT04366726) | Radius Health, Inc. | 2019-04-09 |
| G56W1 in Women With Postmenopausal Osteoporosis (NCT03720886) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2018-10-01 |
| MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis (NCT03472846) | Medical University of Vienna | 2017-03-01 |
| A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis (NCT02791516) | Amgen | 2017-01-16 |
| CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome (NCT02981732) | xuhuijuan | 2016-10-01 |
| Dried Plums and Bone Health in Postmenopausal Women (NCT02822378) | Penn State University | 2016-06-01 |
| Moringa Oleifera on Bone Density (NCT03026660) | Appalachian State University | 2015-07-01 |
| Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation (NCT02499237) | 424 General Military Hospital | 2015-07-01 |
| A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen (NCT02478879) | Zosano Pharma Corporation | 2015-06-01 |
| Denosumab and Teriparatide Study (DATA-HD and DATA-EX) (NCT02176382) | Massachusetts General Hospital | 2014-08-01 |
| A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis (NCT02157948) | Amgen | 2014-05-01 |
| A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis (NCT02016716) | Amgen | 2013-12-03 |
| An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women (NCT01796301) | Amgen | 2013-01-31 |
| Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption (NCT01750086) | Massachusetts General Hospital | 2013-01-01 |
| Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis (NCT01657162) | Radius Health, Inc. | 2012-11-20 |
| VERtebral Fracture Treatment Comparisons in Osteoporotic Women (NCT01709110) | Eli Lilly and Company | 2012-10-01 |
| Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050) (NCT01552122) | Merck Sharp & Dohme LLC | 2012-05-01 |
| Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass (NCT01572545) | Aristotle University Of Thessaloniki | 2012-04-01 |
| Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis (NCT01575834) | Amgen | 2012-03-15 |
| Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1 (NCT01834105) | Fujian Academy of Traditional Chinese Medicine | 2012-01-01 |
| Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis (NCT01668589) | Amgen | 2011-11-28 |
| Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis (NCT01348243) | Chiesi Farmaceutici S.p.A. | 2011-10-01 |
| Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women (NCT01343004) | Radius Health, Inc. | 2011-04-01 |
| Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women (NCT01321723) | Unigene Laboratories Inc. | 2011-02-01 |
| Open-label Study to Evaluate the Effect of MBP-80 on Bone Remodelling (NCT01501344) | Groupe De Recherche En Rhumatologie Et Maladies Osseuses Inc. | 2011-01-01 |
| The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam (NCT01221727) | Amgen | 2010-11-01 |
| Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan (NCT02422069) | Hoffmann-La Roche | 2010-04-01 |
| A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis (NCT01128257) | Hoffmann-La Roche | 2010-04-01 |
| Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis (NCT01406613) | Sheffield Teaching Hospitals NHS Foundation Trust | 2010-03-01 |
| MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012) (NCT00996801) | Merck Sharp & Dohme LLC | 2009-11-01 |
| A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years (NCT00909961) | Novartis Pharmaceuticals | 2009-11-01 |
| A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab (NCT00890981) | Amgen | 2009-07-01 |
| A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates (NCT00936897) | Amgen | 2009-07-01 |
| Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density (NCT00896532) | Amgen | 2009-06-03 |
| A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab (NCT00887965) | Amgen | 2009-06-01 |
| Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women (NCT00918749) | Warner Chilcott | 2009-05-01 |
| Epidemiology, Identification Rate and Treatment Penetration of Osteoporotic Vertebral Fractures in Switzerland (NCT02234414) | Prof. Dr. med. Kurt Lippuner | 2009-02-01 |
| Study Evaluating ASTRA TECH Implant System, OsseoSpeed™ Implants in the Upper Jaw in Women With Osteoporosis (NCT00745121) | Dentsply Sirona Implants and Consumables | 2008-07-16 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects (NCT00676312) | Novartis | 2008-05-01 |
| A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018) (NCT00529373) | Merck Sharp & Dohme LLC | 2007-09-13 |
| Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women (NCT00578981) | Mayo Clinic | 2007-08-01 |
| A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. (NCT00493532) | Hoffmann-La Roche | 2007-06-01 |
| Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women (NCT00395395) | Novartis | 2006-10-01 |
| Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation. (NCT00381251) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Study of Transitioning From Alendronate to Denosumab (NCT00377819) | Amgen | 2006-09-01 |
| Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women (NCT00411125) | Novartis | 2006-08-01 |
| A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. (NCT00545051) | Hoffmann-La Roche | 2006-05-01 |
| A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) (NCT00545363) | Hoffmann-La Roche | 2006-04-01 |
| BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis (NCT00545909) | Hoffmann-La Roche | 2006-03-01 |
| A Study of Monthly Risedronate for Osteoporosis (NCT00247273) | Warner Chilcott | 2005-10-01 |
| Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial (NCT00239629) | Eli Lilly and Company | 2005-09-01 |
| Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women (NCT00165698) | Eisai Co., Ltd. | 2005-05-01 |
| PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia (NCT02598453) | Hoffmann-La Roche | 2005-01-01 |
| Study of Investigational Drug in Osteoporosis (MK-0217-908) (NCT00092053) | Organon and Co | 2004-12-01 |
| Effects of Teriparatide in Postmenopausal Women With Osteoporosis (NCT00079924) | Eli Lilly and Company | 2004-11-01 |
| Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis (NCT00091793) | Amgen | 2004-08-01 |
| A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia (NCT02604836) | Hoffmann-La Roche | 2004-06-01 |
| Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women (NCT00086619) | Massachusetts General Hospital | 2004-05-01 |
| Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate (NCT00778154) | Warner Chilcott | 2004-01-01 |
| Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis. (NCT00238745) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-08-01 |
| Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO (NCT00577421) | Warner Chilcott | 2003-06-01 |
| A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) (NCT00092027) | Organon and Co | 2003-03-19 |
| A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) (NCT00092014) | Organon and Co | 2002-09-01 |
| Prevention of Osteoporosis in Breast Cancer Survivors (NCT00567606) | University of Nebraska | 2002-04-01 |